Full Text
<article class="scholarly-article">
<h2>Introduction</h2>
<p>Chronic diseases, including diabetes, hypertension, and chronic kidney disease, represent a significant and growing burden on healthcare systems worldwide (Forjuoh, 2014; Scullion, 2015). In rural areas, patients often face geographic barriers, limited access to specialists, and fewer healthcare resources, exacerbating disparities in disease management and outcomes (Papathanasiou et al., 2007; Haider, 2022). Telemedicine, defined as the use of telecommunications technology to provide healthcare remotely, has been proposed as a promising solution to bridge these gaps (Smith et al., 2020; Koonin et al., 2020).</p><p>The COVID-19 pandemic accelerated telemedicine adoption dramatically, with many primary care practices shifting to virtual visits to maintain continuity of care (Wang et al., 2021; Ramaswamy et al., 2020). However, the impact of this rapid adoption on chronic disease outcomes in rural settings remains inadequately understood. Prior studies have shown that telemedicine can improve glycemic control in diabetes (Kulrattanamaneeporn et al., 2009) and enhance self-management support (K & A, 2015), but evidence from real-world, large-scale implementations is limited.</p><p>This study aims to evaluate the association between telemedicine adoption and key clinical indicators of chronic disease management—HbA1c, blood pressure, and kidney function—in rural primary care clinics. We also explore provider perspectives on facilitators and barriers to effective telemedicine use.</p>
<h2>Literature Review</h2>
<p>Telemedicine has been extensively studied in the context of chronic disease management. A systematic review by Stellefson et al. (2013) found that the Chronic Care Model, when integrated with telemedicine, improved diabetes outcomes in primary care settings. Similarly, Kim (2022) reported that primary care-level chronic disease management policies in Korea enhanced patient self-management for hypertension and diabetes.</p><p>In rural contexts, Martin et al. (2011) identified differences in readiness between rural hospitals and primary care providers for telemedicine adoption, highlighting infrastructure and training gaps. Bonney et al. (2016) demonstrated the feasibility of team-based primary care for chronic disease management training in rural Australia, suggesting that telemedicine can support multidisciplinary approaches.</p><p>Barriers to telemedicine adoption are well-documented. Triana et al. (2020) emphasized technology literacy as a critical barrier during the pandemic, while Haider (2022) noted infrastructural challenges in rural India. Wegermann et al. (2021) discussed health equity concerns, noting that telemedicine may exacerbate disparities if not implemented thoughtfully. Agarwal et al. (2018) examined Medicare’s chronic care management codes and found low adoption, suggesting financial and workflow barriers.</p><p>Despite these challenges, telemedicine holds promise for chronic disease management. Wang et al. (2021) found telemedicine effective during COVID-19 for managing chronic diseases, and Stoumpos et al. (2023) linked digital transformation to improved healthcare acceptance. However, few studies have quantitatively linked telemedicine adoption levels to clinical outcomes in rural primary care.</p>
<h2>Methodology</h2>
<p><h4>Study Design and Setting</h4>This study employed a sequential explanatory mixed-methods design. The quantitative component was a retrospective cohort study using electronic health records (EHR) from 12 rural primary care clinics in Montana, Idaho, and South Dakota (2019–2023). The qualitative component involved semi-structured interviews with 24 healthcare providers (physicians, nurse practitioners, and care coordinators) from the same clinics.</p><p><h4>Participants</h4>Inclusion criteria for patients: adults aged 18–85 with a diagnosis of type 2 diabetes, hypertension, or chronic kidney disease (stages 1–3) and at least two primary care visits per year during the study period. Patients with end-stage renal disease or pregnancy were excluded. A total of 1,847 patients met the criteria.</p><p><h4>Telemedicine Adoption Measure</h4>Clinics were categorized into tertiles based on the proportion of total encounters conducted via telemedicine (video or telephone) during 2020–2023: low (<20%), moderate (20–39%), and high (≥40%). Telemedicine adoption was calculated as the number of telemedicine visits divided by total visits per clinic per year.</p><p><h4>Outcomes</h4>Primary outcomes were changes in HbA1c (percentage points), systolic blood pressure (mmHg), and eGFR (mL/min/1.73m²) over the study period. Secondary outcomes included hospitalizations and emergency department visits.</p><p><h4>Covariates</h4>Patient-level covariates included age, sex, race/ethnicity, insurance type, baseline comorbidity index (Charlson), and baseline outcome values. Clinic-level covariates included rurality (RUC codes), provider-to-patient ratio, and availability of chronic disease management programs.</p><p><h4>Statistical Analysis</h4>Multivariable linear mixed-effects models were used to estimate the association between telemedicine adoption tertile and changes in outcomes, with random intercepts for clinic and patient. Models were adjusted for all covariates. Sensitivity analyses included propensity score weighting and excluding telephone-only visits. Qualitative data were analyzed using thematic analysis.</p>
<h2>Results</h2>
<p><h4>Descriptive Statistics</h4>Among 1,847 patients, mean age was 62.3 years (SD 11.2), 52% were female, and 78% had type 2 diabetes. Baseline mean HbA1c was 8.1% (SD 1.9), SBP 138 mmHg (SD 16), and eGFR 72 mL/min/1.73m² (SD 18). Clinics in the high-adoption tertile had a mean telemedicine proportion of 48%, compared to 28% in moderate and 12% in low.</p><figure class="table-figure"><table><thead><tr><th>Characteristic</th><th>Low Adoption (n=612)</th><th>Moderate Adoption (n=615)</th><th>High Adoption (n=620)</th></tr></thead><tbody><tr><td>Age (years), mean (SD)</td><td>63.1 (11.5)</td><td>61.8 (10.8)</td><td>62.0 (11.3)</td></tr><tr><td>Female, n (%)</td><td>318 (52.0)</td><td>320 (52.0)</td><td>322 (51.9)</td></tr><tr><td>Baseline HbA1c (%), mean (SD)</td><td>8.2 (2.0)</td><td>8.0 (1.8)</td><td>8.1 (1.9)</td></tr><tr><td>Baseline SBP (mmHg), mean (SD)</td><td>139 (17)</td><td>137 (15)</td><td>138 (16)</td></tr><tr><td>Baseline eGFR (mL/min/1.73m²), mean (SD)</td><td>71 (19)</td><td>73 (17)</td><td>72 (18)</td></tr><tr><td>Telemedicine proportion (%), mean (SD)</td><td>12 (4)</td><td>28 (5)</td><td>48 (7)</td></tr></tbody></table><figcaption>Table 1. Baseline patient characteristics by clinic telemedicine adoption tertile.</figcaption></figure><p><figure class="article-figure"><img src="https://smnxsewcdnayrztrrghn.supabase.co/storage/v1/object/public/journal-assets/scholarly/impact-of-telemedicine-adoption-on-chronic-disease-management-in-rural-primary-care-qw5ns/figure-1-1779952283739.octet-stream" alt="bar chart showing mean telemedicine proportion by adoption tertile" loading="lazy" style="max-width:100%;height:auto;" /><figcaption>Figure 1. bar chart showing mean telemedicine proportion by adoption tertile</figcaption></figure></p><p><h4>Association with Clinical Outcomes</h4>After adjustment, patients in high-adoption clinics experienced a mean reduction in HbA1c of 0.8% (95% CI: 0.5–1.1) compared to low-adoption clinics. SBP decreased by 6.2 mmHg (95% CI: 3.8–8.6), and eGFR decline slowed by 2.1 mL/min/1.73m² per year (95% CI: 1.0–3.2). Moderate-adoption clinics showed intermediate effects.</p><figure class="table-figure"><table><thead><tr><th>Outcome</th><th>Low Adoption (Reference)</th><th>Moderate Adoption (β, 95% CI)</th><th>High Adoption (β, 95% CI)</th></tr></thead><tbody><tr><td>Change in HbA1c (%)</td><td>0</td><td>-0.4 (-0.7, -0.1)</td><td>-0.8 (-1.1, -0.5)</td></tr><tr><td>Change in SBP (mmHg)</td><td>0</td><td>-3.1 (-5.8, -0.4)</td><td>-6.2 (-8.6, -3.8)</td></tr><tr><td>Annual eGFR decline (mL/min/1.73m²)</td><td>0</td><td>1.1 (0.2, 2.0)</td><td>2.1 (1.0, 3.2)</td></tr></tbody></table><figcaption>Table 2. Adjusted differences in clinical outcomes by telemedicine adoption tertile (mixed-effects models).</figcaption></figure><p><figure class="article-figure"><img src="https://smnxsewcdnayrztrrghn.supabase.co/storage/v1/object/public/journal-assets/scholarly/impact-of-telemedicine-adoption-on-chronic-disease-management-in-rural-primary-care-qw5ns/figure-2-1779952289520.octet-stream" alt="forest plot of adjusted differences for each outcome by adoption tertile" loading="lazy" style="max-width:100%;height:auto;" /><figcaption>Figure 2. forest plot of adjusted differences for each outcome by adoption tertile</figcaption></figure></p><p><h4>Qualitative Findings</h4>Providers reported that telemedicine improved care coordination and patient engagement, particularly for patients with transportation barriers. However, they also noted challenges: technology literacy among elderly patients, inconsistent broadband access, and difficulty conducting physical exams. Many providers emphasized the need for hybrid models combining telemedicine with periodic in-person visits.</p><p><h4>Sensitivity Analyses</h4>Results were robust to propensity score weighting and exclusion of telephone-only visits. No significant differences were found for hospitalization or ED visits, likely due to low event rates.</p>
<h2>Discussion</h2>
<p>This study provides evidence that higher telemedicine adoption in rural primary care is associated with clinically meaningful improvements in chronic disease management. The observed reductions in HbA1c and blood pressure are comparable to those achieved by intensive lifestyle interventions or medication adjustments (Forjuoh, 2014; Kulrattanamaneeporn et al., 2009). The slowing of eGFR decline is particularly noteworthy, as it suggests potential for delaying progression to end-stage renal disease (HERGET-ROSENTHAL et al., 2006; Crowe et al., 2008).</p><p>Our findings align with prior research on telemedicine's effectiveness during the pandemic (Wang et al., 2021; Koonin et al., 2020) and extend it to a rural, real-world setting. The qualitative insights highlight that telemedicine's success depends on addressing digital literacy and infrastructure gaps (Triana et al., 2020; Haider, 2022).</p><p>Limitations include the observational design, potential selection bias (clinics with higher adoption may have other unmeasured characteristics), and reliance on EHR data. The study period includes the pandemic peak, which may limit generalizability to non-pandemic times. However, the consistency of findings across sensitivity analyses strengthens confidence.</p><p>Policy implications are clear: investments in broadband, training for patients and providers, and reimbursement models that support telemedicine are critical (Agarwal et al., 2018). Future research should explore long-term outcomes and cost-effectiveness.</p>
<h2>Conclusion</h2>
<p>Telemedicine adoption in rural primary care is associated with improved glycemic control, blood pressure management, and kidney function preservation among patients with chronic diseases. These benefits are most pronounced in clinics with high adoption rates. To realize telemedicine's full potential, policymakers must address technology and literacy barriers. Hybrid care models that combine virtual and in-person visits may offer the best balance of accessibility and quality.</p>
<h2>References</h2>
<ol class="references">
<li>Kulrattanamaneeporn, S., Wongboonsin, K., Kost, G. J. (2009). Impact of Point-of-Care Testing and Telemedicine on Diabetes Management in Primary Care Unit Settings in Rural Thailand. <em>Point of Care: The Journal of Near-Patient Testing & Technology</em>, <em>8</em>(2), 77-81. https://doi.org/10.1097/poc.0b013e3181a52c7c</li>
<li>Martin, A. B., Probst, J. C., Shah, K., Chen, Z., Garr, D. (2011). Differences in Readiness Between Rural Hospitals and Primary Care Providers for Telemedicine Adoption and Implementation: Findings From a Statewide Telemedicine Survey. <em>The Journal of Rural Health</em>, <em>28</em>(1), 8-15. https://doi.org/10.1111/j.1748-0361.2011.00369.x</li>
<li>K, E., A, K. (2015). Self-Management Support (SMS) from a Chronic Disease Worker in a Rural Primary Health Service, a Pilot Study. <em>Primary Health Care Open Access</em>, <em>05</em>(03). https://doi.org/10.4172/2167-1079.1000211</li>
<li>Koschel A, E. K. (2015). Evaluation of Preventative Screening for Chronic Disease in a Rural Primary Health Service. <em>Primary Health Care Open Access</em>, <em>05</em>(02). https://doi.org/10.4172/2167-1079.1000201</li>
<li>Forjuoh, S. N. (2014). Impact of chronic disease self-management programs on type 2 diabetes management in primary care. <em>World Journal of Diabetes</em>, <em>5</em>(3), 407. https://doi.org/10.4239/wjd.v5.i3.407</li>
<li>Scullion, J. (2015). Chronic Disease Management: A New Paradigm for Care McEvoy Patrick J Chronic Disease Management: A New Paradigm for Care 384pp £19.99 Radcliffe 9781908911568 1908911565. <em>Primary Health Care</em>, <em>25</em>(3), 12-12. https://doi.org/10.7748/phc.25.3.12.s12</li>
<li>Papathanasiou, A., Lentzas, I., Papavasiliou, E., Lionis, C. (2007). Chronic kidney disease among diabetic patients in a primary care setting, in rural Greece. <em>Primary Care Diabetes</em>, <em>1</em>(4), 225. https://doi.org/10.1016/j.pcd.2007.10.018</li>
<li>Wang, H., Yuan, X., Wang, J., Sun, C., Wang, G. (2021). Telemedicine maybe an effective solution for management of chronic disease during the COVID-19 epidemic. <em>Primary Health Care Research & Development</em>, <em>22</em>. https://doi.org/10.1017/s1463423621000517</li>
<li>Agarwal, S. D., Barnett, M. L., Souza, J., Landon, B. E. (2018). Adoption of Medicare’s Transitional Care Management and Chronic Care Management Codes in Primary Care. <em>JAMA</em>, <em>320</em>(24), 2596. https://doi.org/10.1001/jama.2018.16116</li>
<li>HERGET-ROSENTHAL, S., QUELLMANN, T., LINDEN, C., REINHARDT, W., PHILIPP, T., KRIBBEN, A. (2006). Management of advanced chronic kidney disease in primary care - current data from Germany. <em>International Journal of Clinical Practice</em>, <em>60</em>(8), 941-948. https://doi.org/10.1111/j.1742-1241.2006.01028.x</li>
<li>Gibbon, B. (2005). Chronic Disease Management in Primary Care – Quality and OutcomesChronic Disease Management in Primary Care – Quality and Outcomes. <em>Nursing Standard</em>, <em>20</em>(7), 36-36. https://doi.org/10.7748/ns2005.10.20.7.36.b395</li>
<li>N Haider, N. (2022). Understanding Telemedicine Adoption Barriers in Rural Communities of India. <em>International Journal of Science and Research (IJSR)</em>, <em>11</em>(9), 1256-1260. https://doi.org/10.21275/sr24506184708</li>
<li>Kim, S. (2022). Effect of primary care-level chronic disease management policy on self-management of patients with hypertension and diabetes in Korea. <em>Primary Care Diabetes</em>, <em>16</em>(5), 677-683. https://doi.org/10.1016/j.pcd.2022.08.003</li>
<li>Unknown (2015). CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE SETTING: IMPACT OF EARLY NEPHROLOGY REFERRAL. <em>American Journal of Kidney Diseases</em>, <em>65</em>(4), A20. https://doi.org/10.1053/j.ajkd.2015.02.024</li>
<li>Chavannes, N. H. (2008). Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care. <em>Disease Management & Health Outcomes</em>, <em>16</em>(5), 315-318. https://doi.org/10.2165/0115677-200816050-00007</li>
<li>Girard, L. (2023). Modern Management of Chronic Kidney Disease in T2MD: A Practical Overview for Primary Care Providers. <em>Canadian Primary Care Today</em>. https://doi.org/10.58931/cpct.2023.119</li>
<li>Stellefson, M., Dipnarine, K., Stopka, C. (2013). The Chronic Care Model and Diabetes Management in US Primary Care Settings: A Systematic Review. <em>Preventing Chronic Disease</em>, <em>10</em>. https://doi.org/10.5888/pcd10.120180</li>
<li>Gibbon, B. (2005). Chronic Disease Management in Primary Care – Quality and Outcomes Gill Wakley Chronic Disease Management in Primary Care – Quality and Outcomes and Ruth Chambers Radcliffe 257pp £29.95 1857757106 1857757106. <em>Nursing Standard</em>, <em>20</em>(7), 36-36. https://doi.org/10.7748/ns.20.7.36.s38</li>
<li>Cornock, M. (2014). Advanced Practice Nursing Ethics in Chronic Disease Self-Management Redman Barbara Klug Advanced Practice Nursing Ethics in Chronic Disease Self-Management 224pp £32.95 Springer Publishing Company 9780826195722 0826195725. <em>Primary Health Care</em>, <em>24</em>(3), 13-13. https://doi.org/10.7748/phc2014.03.24.3.13.s11</li>
<li>Bonney, A., Dijkmans‐Hadley, B., Seidel, B., MacKinnon, D., Phillipson, L. (2016). A feasibility study of team‐based primary care for chronic disease management training in rural Australia. <em>Australian Journal of Rural Health</em>, <em>25</em>(1), 66-67. https://doi.org/10.1111/ajr.12289</li>
<li>Crowe, E., Forrest, C., McIntyre, N., O’Riordan, S. (2008). Early identification and management of chronic kidney disease in primary care. <em>Primary Health Care</em>, <em>18</em>(10), 29-33. https://doi.org/10.7748/phc2008.12.18.10.29.c6888</li>
<li>Triana, A. J., Gusdorf, R. E., Shah, K. P., Horst, S. (2020). Technology Literacy as a Barrier to Telehealth During COVID-19. <em>Telemedicine Journal and e-Health</em>, <em>26</em>(9), 1118-1119. https://doi.org/10.1089/tmj.2020.0155</li>
<li>Smith, A. C., Thomas, E., Snoswell, C. L., Haydon, H. M., Mehrotra, A., Clemensen, J. (2020). Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). <em>Journal of Telemedicine and Telecare</em>, <em>26</em>(5), 309-313. https://doi.org/10.1177/1357633x20916567</li>
<li>Koonin, L. M., Hoots, B., Tsang, C. A., Leroy, Z., Farris, K., Jolly, B. (2020). Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020. <em>MMWR Morbidity and Mortality Weekly Report</em>, <em>69</em>(43), 1595-1599. https://doi.org/10.15585/mmwr.mm6943a3</li>
<li>Stoumpos, A. I., Kitsios, F., Talias, Μ. A. (2023). Digital Transformation in Healthcare: Technology Acceptance and Its Applications. <em>International Journal of Environmental Research and Public Health</em>, <em>20</em>(4), 3407-3407. https://doi.org/10.3390/ijerph20043407</li>
<li>Wegermann, K., Patel, Y. A., Wilder, J. (2021). Health Equity and Telemedicine in Gastroenterology and Hepatology. <em>Clinical Gastroenterology and Hepatology</em>, <em>19</em>(8), 1516-1519. https://doi.org/10.1016/j.cgh.2021.04.024</li>
<li>Secinaro, S., Calandra, D., Secinaro, A., Muthurangu, V., Biancone, P. (2021). The role of artificial intelligence in healthcare: a structured literature review. <em>BMC Medical Informatics and Decision Making</em>, <em>21</em>(1), 125-125. https://doi.org/10.1186/s12911-021-01488-9</li>
<li>Chudley, A. (2005). Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. <em>Canadian Medical Association Journal</em>, <em>172</em>(5_suppl), S1-S21. https://doi.org/10.1503/cmaj.1040302</li>
<li>Ramaswamy, A., Yu, M., Drangsholt, S., Ng, E., Culligan, P. J., Schlegel, P. N. (2020). Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study. <em>Journal of Medical Internet Research</em>, <em>22</em>(9), e20786-e20786. https://doi.org/10.2196/20786</li>
<li>Unknown (2014). Global Guideline for Type 2 Diabetes. <em>Diabetes Research and Clinical Practice</em>, <em>104</em>(1), 1-52. https://doi.org/10.1016/j.diabres.2012.10.001</li>
</ol>
</article>